298 related articles for article (PubMed ID: 18284387)
1. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Kivisaari AK; Kallajoki M; Ala-aho R; McGrath JA; Bauer JW; Königová R; Medvecz M; Beckert W; Grénman R; Kähäri VM
Br J Dermatol; 2010 Oct; 163(4):726-35. PubMed ID: 20586780
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
4. Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7.
Hartmann-Petersen S; Tammi RH; Tammi MI; Kosma VM
Br J Dermatol; 2009 Jun; 160(6):1251-7. PubMed ID: 19222463
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
6. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
[TBL] [Abstract][Full Text] [Related]
7. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Impola U; Jeskanen L; Ravanti L; Syrjänen S; Baldursson B; Kähäri VM; Saarialho-Kere U
Br J Dermatol; 2005 Apr; 152(4):720-6. PubMed ID: 15840104
[TBL] [Abstract][Full Text] [Related]
9. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
Kerkelä E; Ala-aho R; Klemi P; Grénman S; Shapiro SD; Kähäri VM; Saarialho-Kere U
J Pathol; 2002 Oct; 198(2):258-69. PubMed ID: 12237887
[TBL] [Abstract][Full Text] [Related]
10. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
[TBL] [Abstract][Full Text] [Related]
11. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa.
Rokunohe A; Nakano H; Aizu T; Kaneko T; Nakajima K; Ikenaga S; Matsuzaki Y; Murai T; Tamai K; Sawamura D
J Dermatol; 2008 Jun; 35(6):336-40. PubMed ID: 18578710
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
[TBL] [Abstract][Full Text] [Related]
14. MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa.
Hata H; Abe R; Suto A; Homma E; Fujita Y; Aoyagi S; Shimizu H
Br J Dermatol; 2015 Mar; 172(3):769-73. PubMed ID: 25066310
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa: report of eight tumours in four patients.
Bosch RJ; Gallardo MA; Ruiz del Portal G; Snchez P; Arce MF; Herrera E
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):198-204. PubMed ID: 10642056
[TBL] [Abstract][Full Text] [Related]
17. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
[TBL] [Abstract][Full Text] [Related]
18. Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma.
Roh MR; Zheng Z; Kim HS; Kwon JE; Jeung HC; Rha SY; Chung KY
Exp Mol Pathol; 2012 Apr; 92(2):236-42. PubMed ID: 22305927
[TBL] [Abstract][Full Text] [Related]
19. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin.
Fine JD; Johnson LB; Weiner M; Stein A; Suchindran C
J Am Acad Dermatol; 2004 Apr; 50(4):563-71. PubMed ID: 15034505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
